As the director of a weight loss clinic, I’m thrilled to share some eye-opening insights from a recent KFF Health Tracking Poll. It turns out, 1 in 8 U.S. adults have tried GLP-1 agonist drugs like Wegovy, Ozempic, Zepbound, or Mounjaro. That’s a significant number of people turning to medication for help with their weight loss journey!
Interestingly, 61% of these individuals are using these drugs to manage chronic conditions such as diabetes or heart disease, not just for being overweight.1. In fact, 43% of the users are diabetics, and 26% have heart disease. It’s no surprise since GLP-1 agonists were initially developed for Type 2 diabetes treatment2.
But here’s the kicker – nearly 38% of users are taking these drugs solely to shed pounds. And with Wegovy’s recent FDA approval for reducing heart attack and stroke risks, it’s clear that these medications are more than just weight loss tools3.
Now, let’s talk cost. These drugs don’t come cheap, with prices soaring over $1,000 for a month’s supply before insurance4. And despite insurance coverage, about 54% of users find it “difficult” to afford them5.
By the way - Our patients pay just $299/mo to start on Semaglutide or $399 for Tirzepatide. Call us now if you want to start your weight loss journey now.
The poll also highlighted a growing awareness and demand for Medicare coverage for these drugs among adults, regardless of age or political views. So, as we navigate the complexities of weight loss treatments, it’s essential to stay informed and advocate for accessible healthcare solutions.
Remember, at our clinic, we’re here to support you every step of the way – from exploring medication options to personalized lifestyle changes. Let’s work together towards a healthier, happier you!
Pacific Northwest Medical Group
6622 112th ST E, Puyallup WA 98373
253-340-2270
Book a FREE consult now <- Click There!